Advertisement
Screener

RESPONSE BIOMEDICAL CORP Accounts Receivable

RESPONSE BIOMEDICAL CORP Accounts Receivable

RESPONSE BIOMEDICAL CORP had Accounts Receivable of CAD 425.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:AccountsReceivableNetCurrent · last filed 2016-11-14

  • 2016-09-30: Accounts Receivable, after Allowance for Credit Loss, Current 425.00K CAD.
  • 2016-06-30: Accounts Receivable, after Allowance for Credit Loss, Current 442.00K CAD.
  • 2016-03-31: Accounts Receivable, after Allowance for Credit Loss, Current 614.00K CAD.
  • 2015-12-31: Accounts Receivable, after Allowance for Credit Loss, Current 466.00K CAD.
Period endAccounts Receivable, after Allowance for Credit Loss, CurrentAccounts Receivable, after Allowance for Credit Loss, Current as first filed
2016-09-30425.00K CAD
10-Q · filed 2016-11-14
2016-06-30442.00K CAD
10-Q · filed 2016-08-15
2016-03-31614.00K CAD
10-Q · filed 2016-05-16
2015-12-31466.00K CAD
10-Q · filed 2016-11-14
2015-09-30445.00K CAD
10-Q · filed 2015-11-13
2015-06-301.90M CAD
10-Q · filed 2015-08-14
2015-03-311.71M CAD
10-Q · filed 2015-05-08
2014-12-31702.00K CAD
10-K · filed 2016-03-24
2014-09-30323.00K CAD
10-Q · filed 2014-11-13
2014-06-30709.00K CAD
10-Q · filed 2014-08-13
2014-03-31403.00K CAD
10-Q · filed 2014-05-14
2013-12-31875.00K CAD
10-K · filed 2015-03-19
2013-09-30757.00K CAD
10-Q · filed 2013-11-13
2013-06-301.57M CAD
10-Q · filed 2013-08-13
2013-03-311.80M CAD
10-Q · filed 2013-05-14
2012-12-311.48M CAD
10-K · filed 2014-03-17
1.48M CAD
10-K · filed 2013-03-15
2012-09-301.23M CAD
10-Q · filed 2012-11-14
2012-06-301.69M CAD
10-Q · filed 2012-08-09
2012-03-312.25M CAD
10-Q · filed 2012-05-08
2011-12-311.56M CAD
10-K · filed 2013-03-15
2010-12-311.22M CAD
10-K · filed 2012-03-29